Cardiff Oncology, Inc.
Status: Publicly traded
Direct answer
Cardiff Oncology, Inc. is publicly traded on NASDAQ under the ticker CRDF.
Cardiff Oncology, Inc., a clinical-stage biotechnology firm located in San Diego, California, is dedicated to developing innovative medical treatments for cancer patients. Its lead therapeutic agent is onvansertib, an oral and selective inhibitor of Polo-like Kinase 1 (PLK1), which is being investigated for various anti-cancer applications, including clinical trials for metastatic colorectal cancer. The company's...
Can you invest in Cardiff Oncology, Inc.?
Yes. Cardiff Oncology, Inc. trades publicly on NASDAQ as CRDF.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cardiff Oncology, Inc.
Detailed equity research is provided by MarketSnap.